MedTrace Logo

Supplementation of Oil Palm Phenolics to Healthy Participants

NCT04164446 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-12-23

No results posted yet for this study

Summary

Our previous study has found that oil palm phenolics (OPP) supplementation at 9 grams per day is safe for consumption. An interesting observation was reported where the consumption of OPP showed significantly lower total and LDL cholesterol compared to the control group. There is no clinical evidence as yet on the optimum dosage of OPP supplementation in improving fasting lipid profile. We hypothesize that in a clinical study, OPP supplemented participants will elicit a reduction in total and LDL cholesterol while maintaining safety and tolerability.

Conditions

Interventions

DRUG

Placebos

The placebo that will be used contains starch and glucose.

DIETARY_SUPPLEMENT

Oil Palm Phenolics

One capsule contains 250 mg OPP or 1 g OPP

Sponsors & Collaborators

  • Malaysia Palm Oil Board

    collaborator OTHER_GOV

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Isa Naina Mohamed, MD, PhD · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-16
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04164446 on ClinicalTrials.gov